Defining the Gut-Mammary Gland-Secretory IgA Axis in Porcine Epidemic Diarrhea Virus Infected Gilts and its Impact on Lactogenic Immune Protection of Neonatal Suckling Piglets
Year: 2018
Type: article
Abstract: Neonates are immune competent but immunologically immature at birth and are highly susceptible to enteric pathogens.For example, porcine epidemic diarrhea virus (PEDV) is a highly virulent re-emerging enteric coronavirus that causes acute diarrhea, dehydration and 80-100% mortality in neonatal piglets.Since its emergence in the United States (US) in 2013, PEDV caused over 8.5 million piglet deaths and $900 million to $1.8 billion in losses to US swine producers in 2014.Lactogenic immunity remains the most promising and effective way to protect neonatal suckling piglets from enteric diseases like PEDV.This is particularly true for domesticated animals like swine and cattle whose epitheliochorial placenta inhibits immunoglobulin (Ig) transfer in utero.Therefore, colostrum [first secretions from the mammary gland (MG)] and milk-derived antibodies (Abs) and other immune factors are the sole source for immune protection after birth.Passive lactogenic immunity is achieved through high titers of IgG Abs in colostrum and a continuous supply of secretory IgA (sIgA) Abs in milk.Specifically, because of their persistence in milk at high titers, sIgA Abs play a major role in conferring passive lactogenic protection against enteric pathogens in suckling neonates.Therefore, our goal was to improve the understanding of maternal and lactogenic immunity induced via the gut-MG-sIgA axis and its role in protection against PEDV in neonatal suckling piglets.iv Our first objective was to study the impact of stage of gestation at time of PEDV infection in pregnant gilts and its implications for generation of lactogenic immunity and protection of PEDV-challenged piglets.To understand how stage of gestation affects maternal immune responses to PEDV, three groups of gilts were orally infected with PEDV in the first, second or third trimester.Control (mock) gilts were inoculated with medium in the third trimester.To determine if lactogenic immunity correlated with protection, all piglets were PEDV-challenged at 3-5 days postpartum.PEDV infection of gilts at different stages of gestation significantly affected multiple maternal systemic immune parameters prepartum, including natural killer (NK) cells, cytokines, B cells and PEDV Abs and antibody secreting cells (ASCs).Second trimester gilts had significantly higher circulating PEDV IgA and IgG Abs and ASCs and PEDV virus neutralizing (VN) Abs post PEDV infection.Coinciding with the significantly higher PEDV Ab responses in second trimester gilts, the survival rate of their PEDV-challenged piglets was 100%, 87.2%, 55.9% and 5.7% for first, third and mock litters, respectively.Additionally, piglet survival positively correlated with PEDV IgA Abs and ASCs and VN Abs in milk and PEDV IgA and IgG Abs in piglet serum.Our findings have implications for gestational timing of oral attenuated PEDV maternal vaccines, whereby PEDV intestinal infection in the second trimester optimally stimulated the gut-MG-sIgA axis resulting in 100% lactogenic immune protection in suckling piglets.Our second objective was to study the impact of vitamin A (VA), an essential micronutrient, on maternal immunity and lactogenic immune protection of neonatal suckling piglets.Gilts received daily oral retinyl acetate (30,000 IU) starting at gestation v day 76 throughout lactation.At 3-4 weeks prepartum, VA-supplemented (PEDV+VA) and non-supplemented (PEDV) gilts were PEDV or mock inoculated (mock+VA and mock, respectively).PEDV+VA gilts had lower mean PEDV RNA shedding titers and mean diarrhea scores, coinciding with increased frequencies of circulating NK cells post PEDV infection.Nursing piglets were PEDV-challenged at 3-5 days postpartum.The survival rate of PEDV+VA litters was 74.2% compared with 55.9% in PEDV litters.Mock and mock+VA litters had 5.7% and 8.3% survival rates, respectively.PEDV+VA gilts had increased PEDV IgA ASCs and Abs and IgA + β7 + (gut homing) cells in serum prepartum and in milk post-partum at post piglet challenge day (PCD) 5-9.Our findings suggest that oral VA supplementation may act as an adjuvant during pregnancy, enhancing IgA ASC trafficking via the gut-MG-sIgA axis and lactogenic immune protection in nursing piglets.Our third objective was to characterize B lymphocytes and immunoglobulin secreting cells (IgSCs) in colostrum, milk and MG tissue and cytokines in colostrum and milk of lactating swine.B lymphocytes were mainly CD2 +/-CD21 -(Ig-producing and/or memory) with few CD2 + CD21 + (naïve) cells.We observed large numbers of IgSCs in colostrum and milk with significantly higher IgG IgSCs in colostrum and IgA and IgM IgSCs in late lactation milk.Additionally, milk contained α4 + β7 + (gut homing receptor) B lymphocytes and enteric virus-specific IgG and IgA ASCs.TGF-β was the dominant cytokine in MG secretions and the concentration of IL-17 and IL-22 increased in mid and late lactation milk.Our results demonstrate that porcine milk contains Ig-producing B cells, many of which originate from the intestine, and pro/anti-inflammatory cytokines.vi Our findings demonstrate that second trimester gilts have the greatest capacity to generate a robust PEDV humoral immune response prior to parturition, resulting in the highest amount of lactogenic immune protection against PEDV challenge in neonatal suckling piglets.Additionally, it suggests pregnancy should not be evaluated as a single event and development of a successful attenuated PEDV vaccine requires consideration of stage of gestation at the time of vaccination.Additionally, our results show that oral VA supplementation can be used as a cost-effective strategy to stimulate and enhance the gut-MG-sIgA axis to increase lactogenic immune protection of neonatal suckling piglets.Lastly, our results provide a better understanding of swine colostrum, milk and MG tissue B lymphocytes and colostrum and milk cytokines that may facilitate future studies investigating their role in neonatal immune development and protection.Understanding the gut-MG-sIgA axis and lactogenic immunity is critical to advance animal health and welfare within the swine industry.Additionally, the similarities between the human and swine immune systems make the pig a viable translational animal model, particularly for the study of infectious disease and vaccine development during pregnancy.Our pregnant swine model is applicable to endemic and emerging enteric viral diseases in humans and animals, as similar maternal vaccination strategies may be needed to enhance the gut-MG-sIgA axis and neonatal protection.
Author: Langel, Stephanie Mary Neal
Institution: The Ohio State University
Language: English
Subfield: Animal Science and Zoology
Domain: Life Sciences
Keywords: porcine epidemic diarrhea virus, secretory IgA, lactogenic immunity, maternal immunity, gilts, newborn piglets, suckling piglets, colostrum, milk antibodies, intestinal epithelium, intestinal permeability, intestinal barrier, natural killer cells, cytokines, B cells, IgG, enteric coronavirus
Open Access status: green
OpenAlex ID: W7027622680
